StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: AEterna Zentaris, Incorporated

Enter Symbol or Keywords

Aeterna Zentaris' OPS Ranking of "3" Reiterated by StockDiagnostics.com

Stock Quote: (NGM:AEZS)

11/16/2009

0.82

-0.0016

-0.20%

53,195

Aeterna Zentaris' OPS Ranking of "3" Reiterated by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 16, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "3" for Aeterna Zentaris Inc. (NASDAQ:AEZS). Aeterna Zentaris has had an OPS Ranking of "3" fo ... read full story

Website Address:	www.aezsinc.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: AEZS

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: AEZS

11/18/2009

Two Year High in EBITDA for Aeterna Zentaris

11/16/2009

Aeterna Zentaris Experiencing Revenue Downtrend While its Industry is in an Uptrend

11/16/2009

Aeterna Zentaris' OPS Ranking of "3" Reiterated by StockDiagnostics.com

... more AEZS exclusives

Other News Sources: AEZS

02/03/2010

AEterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer

01/29/2010

AEterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia

01/29/2010

Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia

... more AEZS news from other sources

Daily Market Updates

02/09/2010

Rally Continues at Midday on Reports of EU Support for Greece

The indices continue to rally at midday, and stocks have seen their best one-day performance since July 2009 during this session after an easing of fears regarding sovereign debt issues in Europe. An earlier report today had indictated that the Euro ... read full story